$CLRC
ClimateRock Stock $clrc

$clrc Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023012940 Filed on February 17, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$733.8K	$1.768M
YoY Change		37281.61%
Operating Profit		-$1.768M	-$4.730K
YoY Change
Interest Expense	$652.0K	$1.092M
YoY Change
% of Operating Profit
Other Income/Expense, Net		$1.092M
YoY Change
Pretax Income	-$81.82K	-$675.9K
YoY Change		14189.01%
Income Tax
% Of Pretax Income
Net Earnings	-$81.82K	-$675.9K	-$4.730K
YoY Change	1629.81%	14189.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$0.07
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$81.45M	$81.45M
YoY Change
Cash & Equivalents	$411.7K	$81.04M
Short-Term Investments
Other Short-Term Assets	$106.5K	$106.5K
YoY Change		27.84%
Inventory
Prepaid Expenses	$106.5K
Receivables
Other Receivables
Total Short-Term Assets	$81.56M	$81.56M	$83.34K
YoY Change	97757.47%	97761.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$81.56M	$81.56M	$83.34K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$81.56M	$81.56M	$83.34K
YoY Change	97757.47%	97761.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$1.006M	$3.368M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$480.0K	$480.0K
YoY Change		661.06%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.848M	$3.848M	$63.07K
YoY Change	6001.22%	6001.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.848M	$3.848M	$63.07K
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$3.848M	$3.848M	$63.07K
YoY Change	6001.22%	6001.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.330M		-$4.730K
YoY Change	70305.41%
Common Stock	$12.00		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	946.2K shares
Shareholders Equity	-$3.330M	$77.71M	$20.27K
YoY Change
Total Liabilities & Shareholders Equity	$81.56M	$81.56M	$83.34K
YoY Change	97757.47%	97761.0%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$81.82K	-$675.9K	-$4.730K
YoY Change	1629.81%	14189.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$252.2K	-$884.5K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$79.93M
YoY Change
Cash From Investing Activities	$0.00	-$79.93M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.0K	$81.23M
YoY Change
NET CHANGE
Cash From Operating Activities	-252.2K	-$884.5K
Cash From Investing Activities	0.000	-$79.93M
Cash From Financing Activities	300.0K	$81.23M
Net Change In Cash	47.82K	$411.7K	$0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$252.2K	-$884.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2021Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		usd
CY2021Q4	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	83343	usd
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SW3 3DD
CY2022	dei	Entity Address Country EntityAddressCountry	GB
CY2022	dei	City Area Code CityAreaCode	+44
CY2022	dei	Local Phone Number LocalPhoneNumber	203 954 0590
CY2022	dei	Security12b Title Security12bTitle	Class A Ordinary Shares, par value $0.0001 per share
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41363
CY2022	dei	Entity Registrant Name EntityRegistrantName	CLIMATEROCK
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	50 Sloane Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2022	dei	Trading Symbol TradingSymbol	CLRC
CY2022Q4	us-gaap	Assets Current AssetsCurrent	81557355	usd
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	77962500	usd
CY2022	dei	Auditor Firm AuditorFirmId	1195
CY2022	dei	Auditor Name AuditorName	UHY LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	411711	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	106542	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	83343	usd
CY2022Q4	us-gaap	Assets Assets	81557355	usd
CY2021Q4	us-gaap	Assets Assets	83343	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1005720	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	81039102	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	480000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	63073	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	2362500	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3848220	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	63073	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3848220	usd
CY2021Q4	us-gaap	Liabilities Liabilities	63073	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	81039102	usd
CY2022Q4	clcr	Total Commitment And Contingencies TotalCommitmentAndContingencies	81039102	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12	usd
CY2022Q4	clcr	Common Stock Value One CommonStockValueOne	197	usd
CY2021Q4	clcr	Common Stock Value One CommonStockValueOne	216	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24784	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3330176	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4730	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3329967	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20270	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81557355	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83343	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1768147	usd
CY2021Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4730	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1768147	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-4730	usd
CY2022	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	1107852	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-15579	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1092273	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-4730	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-4730	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20270	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	187500	usd
CY2022	clcr	Sale Of Unit SaleOfUnit	7875000	shares
CY2022	clcr	Sale Of Per Unit SaleOfPerUnit	10
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73656058	usd
CY2022	clcr	Issuance Of Underwriter Units IssuanceOfUnderwriterUnits	118125	shares
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	946181	usd
CY2022	clcr	Sale Of Warrants SaleOfWarrants	3762500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3762500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-81039102	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3329967	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-4730	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	1107852	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-15579	usd
CY2021Q4	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	4730	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	990141	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	106542	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-884548	usd
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	79931250	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79931250	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	485150	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	217641	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	78750000	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	1552500	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3762500	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81227509	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	411711	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411711	usd
CY2022	clcr	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	149418	usd
CY2021Q4	clcr	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	83343	usd
CY2022	clcr	Deferred Underwriting Commission Charged To Additional Paid In Capital DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital	2362500	usd
CY2022	clcr	Allocation Of Offering Costs To Class A Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToClassAOrdinarySharesSubjectToRedemption	304011	usd
CY2022	clcr	Issuance Of Representative Shares IssuanceOfRepresentativeShares	946181	usd
CY2022	clcr	Initial Value Of Public Shares Subject To Possible Redemptionin Shares InitialValueOfPublicSharesSubjectToPossibleRedemptioninShares	71851500	usd
CY2022	clcr	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares	-4647702	usd
CY2022	clcr	Remeasurement Adjustment On Public Shares Subject To Possible Redemption RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption	13835304	usd
CY2021Q4	clcr	Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares	25000	usd
CY2022	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1181250	usd
CY2022	us-gaap	Payments For Commissions PaymentsForCommissions	2362500	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	946169	shares
CY2022	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	604011	usd
CY2022	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	79931250	usd
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	411711	usd
CY2022Q4	clcr	Assets Held In Trust Account AssetsHeldInTrustAccount	0.80	pure
CY2022Q4	clcr	Interest Earned On The Funds Held In The Trust Account InterestEarnedOnTheFundsHeldInTheTrustAccount	10.15
CY2022Q4	us-gaap	Deposits Deposits	787500	usd
CY2022Q4	clcr	Deposits Per Share DepositsPerShare	0.1
CY2022Q4	us-gaap	Cash Cash	411711	usd
CY2022Q4	clcr	Working Capital Deficit WorkingCapitalDeficit	967467	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	411711	usd
CY2021Q4	us-gaap	Investments And Cash InvestmentsAndCash	0	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	79931250	usd
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P180D
CY2022Q4	clcr	Cash And Cash Equivalents Held In Trust Account CashAndCashEquivalentsHeldInTrustAccount	81039102	usd
CY2022	clcr	Dividendsvd Held Trust Account DividendsvdHeldTrustAccount	1107852	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	83343	usd
CY2022Q2	us-gaap	Employee Stock Ownership Plan Esop Fair Value Of Shares Subject To Repurchase Obligation EmployeeStockOwnershipPlanESOPFairValueOfSharesSubjectToRepurchaseObligation	4647702	usd
CY2022	clcr	Founder Shares Were No Longer Subject To Forfeiture FounderSharesWereNoLongerSubjectToForfeiture	93750	shares
CY2022	clcr	Subject To Forfeiture Shares SubjectToForfeitureShares	187500	shares
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-675874	usd
CY2021Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4730	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	12727452	usd
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-13403326	usd
CY2021Q4	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-4730	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1107852	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14511178	usd
CY2021Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-4730	usd
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1968750	shares
CY2022	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	1968750	shares
CY2022Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10
CY2022Q2	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	78750000	usd
CY2022	clcr	Gross Proceeds GrossProceeds	78750000	usd
CY2022	clcr	Proceeds Allocated To Public Warrants And Public Rights ProceedsAllocatedToPublicWarrantsAndPublicRights	6898500	usd
CY2022	us-gaap	Partners Capital Account Public Sale Of Units Net Of Offering Costs PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts	4647702	usd
CY2022	clcr	Accretion Of Carrying Value To Redemption Value AccretionOfCarryingValueToRedemptionValue	13835304	usd
CY2022	clcr	Ordinary Shares Subject To Possible Redemption OrdinarySharesSubjectToPossibleRedemption	81039102	usd
CY2022Q2	us-gaap	Partners Capital Distribution Amount Per Share PartnersCapitalDistributionAmountPerShare	11.5
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	375000	shares
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	180000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	300000	usd
CY2022Q2	us-gaap	Sponsor Fees SponsorFees	10000	usd
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	70299	usd
CY2022Q3	clcr	Letter Agreement Description LetterAgreementDescription	the Company entered into an agreement (the “Letter Agreement”) with Gluon Partners LLP (“Gluon”) to pay a fee (the “Transaction Success Fee”) upon completion of one or more successful transactions. The Company will pay Gluon $500,000 upon completion of one or more transactions with an aggregate purchase price of less than $400,000,000; and, an additional $500,000 upon completion of one or more transactions with an aggregate purchase price of more than $400,000,000. This means the total remuneration for transactions with a purchase price more than $400,000,001 would be $1,000,000. The transactions purchase price will correspond to the price paid to the sellers of the applicable target, including cash, debt, and equity funded payments. Each Transaction Success Fee will be payable upon consummation of the applicable transaction, regardless of (i) the calendar for the payment of the purchase price, (ii) how the purchase price is funded, (iii) any deferred payment subsequent to consummation of the transaction, or (iv) any adjustments to the price of the transaction subsequent to consummation. Following payment of Transaction Success Fee, any accrued fees payable to the Gluon Group by the Company will be waived.
CY2022Q4	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	250000	usd
CY2022Q4	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	400000000	usd
CY2022	clcr	Cash Fee Payable Percentage CashFeePayablePercentage	0.02	pure
CY2021Q4	us-gaap	Partners Capital Account Units Treasury PartnersCapitalAccountUnitsTreasury	1125000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	375000	shares
CY2022	us-gaap	Long Term Purchase Commitment Description LongTermPurchaseCommitmentDescription	The underwriters were entitled to an underwriting discount of $0.45 per unit, or $3,543,750 in the aggregate, of which $0.15 per unit, or $1,181,250 was paid upon the closing of the Initial Public Offering. Of the $0.45 discount, the underwriters were entitled to a deferred underwriting commission of $0.30 per unit, or $2,362,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	125000	usd
CY2022Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	125000	usd
CY2022Q4	us-gaap	Servicing Liability At Fair Value Amount ServicingLiabilityAtFairValueAmount	946181	usd
CY2022Q3	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	50000000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	150000	usd
CY2022Q3	us-gaap	Payments For Fees PaymentsForFees	40000000	usd
CY2022Q3	clcr	Transaction Success Fee TransactionSuccessFee	500000	usd
CY2022Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15000	usd
CY2022Q3	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	20000	usd
CY2022Q3	clcr	Aggregate Transaction Value AggregateTransactionValue	400000000	usd
CY2022Q3	clcr	Retainer Fees RetainerFees	40000	usd
CY2022	us-gaap	Transfer Mortgage Payable TransferMortgagePayable	1600000	usd
CY2022	us-gaap	Increase Decrease In Construction Payables IncreaseDecreaseInConstructionPayables	1600000	usd
CY2022	clcr	Aggregate Transaction Value AggregateTransactionValue	300000000	usd
CY2022	clcr	Transaction Purchase Price TransactionPurchasePrice	0.0085	pure
CY2022Q4	us-gaap	Fair Value Option Aggregate Differences Long Term Debt Instruments FairValueOptionAggregateDifferencesLongTermDebtInstruments	300000000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.004	pure
CY2022	clcr	Transaction Success Fee TransactionSuccessFee	1000000	eur
CY2022	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	650000000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	clcr	Deferred Underwriting Commission Charged To Additional Paid In Capital DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital		usd
CY2021Q4	clcr	Allocation Of Offering Costs To Class A Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToClassAOrdinarySharesSubjectToRedemption		usd
CY2021Q4	clcr	Issuance Of Representative Shares IssuanceOfRepresentativeShares		usd
CY2022	clcr	Warrants Redemption Description WarrantsRedemptionDescription	●in whole and not in part; ●at a price of $0.01 per warrant; ●upon a minimum of 30 days’ prior written notice of redemption; and ●if, and only if, the last reported last sale price of the ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
CY2022	clcr	Equity Linked Securities Description EquityLinkedSecuritiesDescription	If: (i) the Company issues additional ordinary shares or securities convertible into or exercisable or exchangeable for shares of ordinary shares for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary shares, with such issue price or effective issue price to be determined in good faith by the Board (and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by such holder or affiliates, as applicable, prior to such issuance) (the “New Issuance Price”); (ii) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation thereof (net of redemptions); and (iii) the volume weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the greater of the Market Value and the New Issuance Price and the Redemption Trigger Price ($18.00) shall be adjusted to equal to 180% of the greater of the Market Value and the Newly Issued Price.
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		usd
CY2021Q4	clcr	Total Commitment And Contingencies TotalCommitmentAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022	us-gaap	Restricted Stock Award Forfeitures Dividends RestrictedStockAwardForfeituresDividends		usd
CY2021Q4	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss		usd
CY2021Q4	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty		usd
CY2021Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
CY2021Q4	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
CY2021Q4	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities		usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2021Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2021Q4	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2021Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021Q4	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2021Q4	clcr	Initial Value Of Public Shares Subject To Possible Redemptionin Shares InitialValueOfPublicSharesSubjectToPossibleRedemptioninShares		usd
CY2021Q4	clcr	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares		usd
CY2021Q4	clcr	Remeasurement Adjustment On Public Shares Subject To Possible Redemption RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption		usd
CY2022	clcr	Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001903392

Files In Submission

Name	View Source	Status
0001213900-23-012940-index-headers.html	Edgar Link	pending
0001213900-23-012940-index.html	Edgar Link	pending
0001213900-23-012940.txt	Edgar Link	pending
0001213900-23-012940-xbrl.zip	Edgar Link	pending
clcr-20221231.xsd	Edgar Link	pending
clcr-20221231_cal.xml	Edgar Link	unprocessable
clcr-20221231_def.xml	Edgar Link	unprocessable
clcr-20221231_pre.xml	Edgar Link	unprocessable
f10k2022ex10-25_climaterock.htm	Edgar Link	pending
f10k2022ex31-1_climaterock.htm	Edgar Link	pending
f10k2022ex31-2_climaterock.htm	Edgar Link	pending
f10k2022ex32-1_climaterock.htm	Edgar Link	pending
f10k2022ex32-2_climaterock.htm	Edgar Link	pending
f10k2022ex4-7_climaterock.htm	Edgar Link	pending
f10k2022_climaterock.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
f10k2022_climaterock_htm.xml	Edgar Link	completed
clcr-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRC
ClimateRock Stock $clrc

2022 Q4 Form 10-K Financial Statement

#000121390023012940 Filed on February 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRC ClimateRock Stock $clrc

2022 Q4 Form 10-K Financial Statement

#000121390023012940 Filed on February 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRC
ClimateRock Stock $clrc